Christopher Stevens's most recent trade in Rocket Pharmaceuticals Inc was a trade of 554,071 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rocket Pharmaceuticals Inc | Christopher Stevens | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2025 | 554,071 | 554,071 | - | - | Stock Option (Right to Buy) | |
| Rocket Pharmaceuticals Inc | Christopher Stevens | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2025 | 407,166 | 407,166 (0%) | 0% | 0 | Common Stock |